Variables | Total |          Fasting triglycerides | P-value | |
---|---|---|---|---|
 |  | <1.2 mmol/L (N = 103) | ≥1.2 mmol/L (N = 226) |  |
Demographics | Â | Â | Â | Â |
  Age, years | 59.3 ± 9.3 | 60.9 ± 9.6 | 58.7 ± 9.1 | 0.043 |
  Male gender | 241 (73.3) | 77 (74.8) | 164 (72.6) | 0.677 |
  Body mass index | 25.5 ± 3.0 | 24.9 ± 3.0 | 25.7 ± 3.0 | 0.045 |
Risk factors | Â | Â | Â | Â |
  Current Smoking | 181 (55.0) | 59 (57.3) | 122 (54.0) | 0.577 |
  Hypertension | 221 (62.1) | 64 (62.1) | 157 (69.5) | 0.189 |
  Hyperlipidemia | 263 (79.9) | 76 (73.8) | 187 (82.7) | 0.060 |
  Peripheral vascular disease | 6 (1.8) | 2 (1.9) | 4 (1.8) | 0.914 |
  Prior Stroke | 13 (4.0) | 4 (3.9) | 9 (4.0) | 0.966 |
  Family history of CAD | 36 (10.9) | 10 (9.7) | 26 (11.5) | 0.628 |
Angiographic findings | Â | Â | Â | 0.481 |
  1-vessel disease | 96 (29.2) | 30 (29.1) | 66 (29.2) |  |
  2-vessel disease | 80 (24.3) | 21 (20.4) | 59 (26.1) |  |
  3-vessel disease | 153 (46.5) | 52 (50.5) | 101 (44.7) |  |
LVEF (%) | 62.0 ± 8.3 | 61.8 ± 8.8 | 62.1 ± 8.1 | 0.749 |
Medical treatment | Â | Â | Â | Â |
  Aspirin | 321 (97.6) | 100 (97.1) | 221 (97.8) | 0.702 |
  Clopidogrel | 315 (95.7) | 100 (97.1) | 215 (95.1) | 0.415 |
  Beta-blocker | 271 (82.7) | 79 (76.7) | 193 (85.4) | 0.053 |
  ACE-I | 85 (25.8) | 29 (28.2) | 56 (24.8) | 0.516 |
  Statin | 320 (97.3) | 101 (98.1) | 219 (96.9) | 0.551 |
DES implantation | 67 (20.4) | 22 (21.4) | 45 (19.9) | 0.762 |